The Purpose of This Study is to Evaluate the Efficacy and Safety of 627 in the Treatment of UC
Clinical trial NCT07507513 · RECRUITING
Trial details
- NCT number
- NCT07507513
- Sponsor
- Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-28
- Primary completion
- 2029-02-28
- Enrollment
- 288
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.